In fact, the pharmacological inhibition or genetic manipulation of P2X7 has been suggested as a strategy for treating MDD (Iwata et al., 2016; Yue et al., 2017; Farooq et al., 2018; Aricioglu et al., 2019). The gene discussed is P2RX7; the disease is major depressive disorder.